A survivor woman after three years of a cardiac tamponade

  • Ana Lilia Peralta-Amaro
    Correspondence
    Corresponding author.
    Affiliations
    Internal Medicine Department, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico

    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico
    Search for articles by this author
  • Adriana Vázquez-Hernández
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Internal Medicine Resident, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
  • Guadalupe Morales-Osorio
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Internal Medicine Resident, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
  • Emily Pecero-García
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Internal Medicine Resident, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
  • Salma Triana-González
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Internal Medicine Resident, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
  • Fernanda Manzo-Carballo
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Internal Medicine Resident, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
  • Elsa Acosta-Jiménez
    Affiliations
    Graduate Studies Division, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Pathology Department, Hospital de Especialidades Centro Médico Nacional “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico
    Search for articles by this author
Published:November 22, 2021DOI:https://doi.org/10.1016/j.jccase.2021.10.010

      Abstract

      Primary pericardial mesothelioma is an extremely rare tumor, of unclear etiology, nonspecific presentation, with a delay in diagnosis, and a poor prognosis. We present the case of a woman with pericardial mesothelioma, whose main manifestation was cardiac tamponade, currently alive three years after diagnosis and undergoing chemotherapy treatment.
      Learning objective: Cardiac tamponade can be the first clinical manifestation of a neoplastic disease, including pericardial mesothelioma, so an adequate diagnostic approach should always be carried out in patients with this clinical picture. Advances in the treatment of pulmonary mesotheliomas have allowed chemotherapy regimens to be adjusted to the treatment of pericardial mesotheliomas, which can increase survival in patients with this type of cancer, which is still considered to have a poor prognosis.

      Keywords

      To read this article in full you will need to make a payment

      References

        • Chen HC
        • Chang S
        • Hsiung MC
        • Kwang WK
        • Tsao TP
        • Yang YN.
        Timely diagnosis of primary pericardial mesothelioma.
        Echocardiography. 2020; 37: 1877-1879
        • Farhat SB
        • Salah M
        • Milouchi S.
        Primary malignant pericardial mesothelioma: a case report.
        Pan Afr Med J. 2020; 36: 375
        • Fels Elliott DR
        • Jones KD
        Diagnosis of mesothelioma.
        Surg Pathol Clin. 2020; 13: 73-89
        • McGehee E
        • Gerber DE
        • Reisch J
        • Dowell JE.
        Treatment and outcomes of primary pericardial mesothelioma: a contemporary review of 103 published cases.
        Clin Lung Cancer. 2019; 20: e152-e157
        • Kowalczuk-Wieteska A
        • Filipiak K
        • Miszalski-Jamka K
        • Nozynski J
        • Zembala M.
        Primary pericardial mesothelioma in a 48-year-old patient.
        Pol Arch Intern Med. 2017; 127: 792-793
        • Cao S
        • Jin S
        • Cao J
        • Shen J
        • Zhang H
        • Meng Q
        • Pan B
        • Yu Y
        Malignant pericardial mesothelioma: A systematic review of current practice.
        Herz. 2018; 43: 61-68
        • Toyokawa G
        • Takenoyama M
        • Hirai F
        • Toyozawa R
        • Inamasu E
        • Kojo M
        • Morodomi Y
        • Shiraishi Y
        • Takenaka T
        • Yamaguchi M
        • Shimokawa M
        • Seto T
        • Ichinose Y.
        Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
        Int J Clin Oncol. 2014; 19: 601-606
        • Rodríguez M
        • Mallidi HR
        • Da Silva A
        • Bueno R
        Recurrence of pericardial mesothelioma affecting the myocardium after pericardial resection.
        Ann Thorac Surg. 2018; 106: e243-e245
        • Matsuyama S
        • Imazuru T
        • Uchiyama M
        • Ota H
        • Iida M
        • Shimokawa T.
        Primary malignant pericardial mesothelioma presenting with cardiac tamponade.
        Int J Surg Case Rep. 2020; 73: 253-256
        • Song G
        • Bi W
        • Zhang X
        • Huang W
        • Zhou K
        • Ren W.
        Localized primary malignant pericardial mesothelioma.
        J Clin Ultrasound. 2019; 47: 178-181